Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Inventory Average (2024 - 2025)

Gyre Therapeutics (GYRE) has disclosed Inventory Average for 2 consecutive years, with $9.5 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 49.61% to $9.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2025, up 49.61% year-over-year, with the annual reading at $8.3 million for FY2025, 55.47% up from the prior year.
  • Inventory Average for Q4 2025 was $9.5 million at Gyre Therapeutics, up from $8.9 million in the prior quarter.
  • The five-year high for Inventory Average was $9.5 million in Q4 2025, with the low at $4.6 million in Q1 2024.